 |
| Medication
Use During Pregnancy and Breastfeeding |
 The
National Center on Birth Defects and Developmental Disabilities has been
actively engaged in activities related to medication exposures during
pregnancy since the 1970’s. Most recent activities include:
Advisory Activities
-
Advise on pharmaceutical industry-based pregnancy registries for
anti-retroviral, anti-epileptic, migraine, and smoking cessation drugs.
-
Serve on Food and Drug Administration Advisory Committees related to
Accutane® (2000, 2004) and pregnancy labeling (1999).
-
Participate in National Children’s Study Working Group on
Medicines/Pharmaceuticals.
-
Funded the Organization of Teratology Information Services to collect
information about risk communication and the occurrence of isotretinoin
(Accutane® ) exposures during pregnancy.
-
Planned, with other participating centers, the analysis of data from
the National Birth Defects Prevention Study
on the effects of medication use during pregnancy.
Workshops and Seminars
-
Medication Use in Pregnancy and Lactation: A
CDC-wide seminar (December, 2004).
-
Pregnancy Exposure Registries: Evaluating the Teratogenic Potential of
Pharmaceutical Products used at Clinical Doses, Drug Information
Association (May, 2004).
-
Use of Herbal Products in Pregnancy, Breastfeeding, and Childhood,
National Children’s Study (2003).
-
Concepts and Strategies To Actively Monitor
the Risks of Medications in Pregnancy (2000). Sponsored by CDC and other
public and private partners. [Click
here to view a PDF of the workshop summary]
Publications
Date: October 29, 2004
Content source: National Center on Birth Defects and Developmental
Disabilities
|
|
|
